Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks
By Olivier Gevaert, Frank De Smet, Dirk Timmerman, Yves Moreau, B. De Moor. Intelligent Systems in Molecular Biology, 2006
371 citations recorded by the source corpus.
Subfields: Artificial Intelligence, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/604b6c30f488df2e0488106b45e9f4812730ec8d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Artificial Intelligence
- Constantin F. Aliferis
- Alexander R. Statnikov
- Ioannis Tsamardinos
- Verónica Bolón-Canedo
- Amparo Alonso-Betanzos
- Noelia Sánchez-Maroño
- Subramani Mani
- Xenofon D. Koutsoukos
In Molecular Biology
- Verónica Bolón-Canedo
- Amparo Alonso-Betanzos
- Noelia Sánchez-Maroño
- Alexander R. Statnikov
- Constantin F. Aliferis
- Ioannis Tsamardinos
- Marinka Zitnik
- José Manuel Benítez
Citations in the corpus
- Data Fusion by Matrix Factorization (2013, background): “This particular approach is often preferred because of its superior predictive accuracy (Pavlidis et al., 2002; Lanckriet et al., 2004b; Gevaert et al., 2006; Tang et al., 2009; van Vliet et al., 2012), but for a given model type, it requires the development of a new inference algorithm.”
- Machine learning applications in cancer prognosis and prediction (2014, neutral): “[52] BN Breast cancer 97 Clinical, microarra”
- A review of microarray datasets and applied feature selection methods (2014, methodology): “Apart from the application of multivariate filter methods [34,126,121,45], the microarray problem was also treated with more complex techniques such as wrappers and embedded methods [22,63,60,97].”
- Local Causal and Markov Blanket Induction for Causal Discovery and Feature Selection for Classification Part I: Algorithms and Empirical Evaluation (2010, background): “In 2006 Gevaert et al. applied K2MB for the purpose of learning classifier that could be used for prognosis of breast cancer from microarray and clinical data (Gevaert et al., 2006) .”